The American Diabetes Association® (ADA) is extremely concerned about the impact of canceled National Institutes of Health funding on the success of the National Diabetes Prevention Program (National DPP), which was established to support people at risk of type 2 diabetes.
Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a…
SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.
Sign up today! Become an Diabetes advocate, use your voice to help people with diabetes thrive.
Digital health interventions were associated with small positive effects on anthropometric measures among children with obesity.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer…
This 45-minute webinar will bring together medical and regulatory experts to discuss the implications of compounded obesity drugs, including potential risks, regulatory challenges, and patient…
Our infographics cover essential topics in diabetes care, serving as visual aids to simplifying complex concepts into actionable insights. We’re committed to empower you and…
Phaeochromocytomas and paragangliomas (PPGLs) release catecholamines leading to catecholamine-induced hypertensive (CIH) crises, with blood pressure greater than or equal to 180/120 mm Hg. CIH crises…
